Andere talen Ajinomoto Co., Inc.

Aandelen

2802

JP3119600009

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5.930 ^JPY	-1,18%		-3,23%	+9,01%

09/05	Transcript : Ajinomoto Co., Inc., 2024 Earnings Call, May 09, 2024
09/05	Ajinomoto Co., Inc. (TSE:2802) kondigt een aandeleninkoopprogramma aan voor 12.500.000 aandelen, wat neerkomt op 2,44% voor ¥50.000 miljoen.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ajinomoto Co., Inc. announces an Equity Buyback for 12,500,000 shares, representing 2.44% for ¥50,000 million.	09/05
Ajinomoto Co., Inc. authorizes a Buyback Plan.	09/05
Ajinomoto : Enhancing Corporate Value through ASV Management	27/03
Ajinomoto : Sustainability Initiatives Aimed at Enhancement of Corporate Value	27/03
TechMagic, Inc. announced that it has received funding from a group of investors	27/03
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium	26/03
Ajinomoto (Malaysia) Closes MYR408 Million Sale of Six Kuala Lumpur Land Plots	12/03
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.	08/03
Ajinomoto Co., Inc.'s Equity Buyback announced on November 13, 2023, has closed with 7,003,300 shares, representing 1.35% for ¥39,999.85 million.	07/03
Tsubame BHB Co., Ltd. announced that it has received ¥5.3 billion in funding from a group of investors	21/02
Ajinomoto Foods Restates Commitment to Quality Products	15/02
Inglewood Co., Ltd. announced that it has received funding from Ajinomoto Co., Inc.	31/01
Ribomic and Ajinomoto Co. Partner for Nucleic Acid Aptamer Research	17/01
Ribomic Enters Into Drug Research Collaboration with Ajinomoto	17/01
RIBOMIC Inc. and Ajinomoto Co., Inc. Announce Joint Research Agreement	16/01
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.	05/01
New acquisition to support global gene therapy manufacturing	14/11
Forge Biologics - Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1	14/11
Ajinomoto Co., Inc. übernimmt Forge Biologics für 620 Millionen Dollar1	13/11
Japan's Ajinomoto to buy US-based Forge Biologics for $546 million	13/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ajinomoto Co., Inc.

Aandelen

2802

JP3119600009

Andere talen

Filters